Skip to main content
. Author manuscript; available in PMC: 2023 Jul 13.
Published in final edited form as: Adv Ther (Weinh). 2019 Sep 30;2(12):1900133. doi: 10.1002/adtp.201900133

Table 1.

Comparisons of different transfection techniques for cell therapies

Fugene® (DNA:Reagent = 1:2.5, 30 uL of reagent-DNA mixture) Viral (lentivirus with ubiquitin promoter, MOI = 10) Bulk electroporation (Biorad, 1000 μF, 500 V, 30 s) Nano-electro injection (NEI) system (30 V, 40 Hz, 200 μs, 2 min)
Net efficiency (Enet) 11.2% 19.5% 16.5% 23.8%
Measured cell doubling time (td)+ 46.8 hr (**) 53.1 hr (**) 50.6 hr (**) 40.0 hr (n.s.)
# days to reach Nfinal (D) 30.1 32.4 31.6 23.9

Starting cell # (N0) = 0.2*106 and final cell # (Nfinal) = 109

Nfinal=N0*Enet*2n, where n is the number of cell divisions. Based on this calculation, the ‘n’ value for Fugene, viral, Biorad and NEI are 15.4, 14.6, 15.0 and 14.4 respectively.

+

tracked for first 4 days after transfection and assuming the value remains unchanged. Our control cells without any transfection treatment doubled every 36.4 hr on average (Table S5).

**

/n.s. indicates p-value <0.001/non-significant respectively compared to control cells, with starting 0.2*106 cells in each condition.

D=n*td